Androstanediol glucuronide

Androstanediol glucuronide
Names
IUPAC name
(3α,5α,17β)-17-Hydroxyandrostan-3-yl β-D-glucopyranosiduronic acid
Identifiers
ChemSpider 20558912
Jmol interactive 3D Image
PubChem 16727166
Properties
C25H40O8
Molar mass 468.59 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Androstanediol glucuronide (ADG) is a metabolite of dihydrotestosterone and testosterone.[1] In women the adrenal steroids, dehydroepiandrosterone sulfate, androstenedione and dehydroepiandrosterone are the major precursors of plasma ADG, accounting for almost the totality of circulating ADG. ADG levels decrease significantly with age.[2] Androstanediol glucuronide is used as a marker of target tissue cellular action. ADG correlates with level of 5 alpha reductase activity (testosterone and androstanediol to dihydrotestosterone) in the skin. ADG is a measure of cutaneous androgen metabolism. it reflects specific type of liver function and the impact of major precursor derived from adrenal glands.[3]

See also

References

  1. Moghissi E, Ablan F, Horton R (September 1984). "Origin of plasma androstanediol glucuronide in men". The Journal of Clinical Endocrinology and Metabolism 59 (3): 417–21. doi:10.1210/jcem-59-3-417. PMID 6746859.
  2. Vermeulen A, Giagulli VA (November 1991). "Physiopathology of plasma androstanediol-glucuronide". The Journal of Steroid Biochemistry and Molecular Biology 39 (5B): 829–33. doi:10.1016/0960-0760(91)90032-z. PMID 1835405.
  3. http://www.hormonetestingmd.com/product_p/androstanediol-glucuronide.htm[]
This article is issued from Wikipedia - version of the Tuesday, July 07, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.